Periarthritis of shoulder
Conditions
Interventions
Control group:Platelet-rich plasma injection
Experimental group:Platelet-rich plasma combined with ozone injection
Sponsors
Department of Pain, Western Theater Command General Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.After shoulder joint release under brachial plexus anesthesia; 2.Aged 40 to 80 years; 3.Voluntarily signed informed consent; 4.Vital signs are stable.
Exclusion criteria
Exclusion criteria: 1.Patients with skin diseases around the injection site, skin ulceration around puncture, or obvious swelling and effusion of joints caused by other diseases that cannot be ruled out; 2.Patients with abnormal coagulation function or undergoing anticoagulation therapy; 3.Serious systemic diseases are not under effective control; 4.Have central nervous system disease, mental disease, can not communicate with normal speech; 5.Contraindications of autotransfusion, such as immunosuppression, tumor or other serious diseases; 6.Other circumstances that the investigator considers inappropriate to participate in the study or cannot cooperate with the study for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale of pain;Oxford University Shoulder Function Score;Imaging changes (X-ray, magnetic resonance imaging, ultrasound, computed tomography); | — |
Secondary
| Measure | Time frame |
|---|---|
| General information of patients (age, sex, body mass index, occupation);Vital signs during treatment (blood pressure, heart rate, oxygen saturation);Adverse reactions;Treatment satisfaction score;Healthy Quality of Life Questionnaire ;Anxiety Self-rating Scale; | — |
Countries
China
Contacts
Public ContactWu Wei
Western Theater Command General Hospital
Outcome results
None listed